Related Experiment Video
Updated: Aug 26, 2026

Propagating and Detecting an Infectious Molecular Clone of Maedi-visna Virus that Expresses Green Fluorescent Protein
Published on: October 9, 2011
AZT inhibits Visna/maedi virus-induced apoptosis
V Bellet1, R Duval, S Delebassée
1Faculté de Pharmacie, Laboratoire de Microbiologie, Limoges, France.
Abstract:
Visna/maedi virus (VMV) causes severe encephalitis and a progressive demyelinating disease in sheep. Previous in vitro studies have demonstrated that VMV-infection leads to apoptosis in sheep choroid plexus cells (SCPC) via induction of both intrinsic and extrinsic pathways with subsequent activation of caspases. 3' azido-2',3'-deoxythymidine (AZT) is a potent and selective Human immunodeficiency virus 1 (HIV-1) reverse transcriptase inhibitor, widely used in antiretroviral therapy; however its effects on retrovirus-induced apoptosis are unknown. Using diverse strategies to detect apoptosis, we analysed the broad range effect of AZT treatment on inhibition of VMV-induced apoptosis. First, we found that AZT treatment inhibited the appearance of characteristic apoptotic morphologic changes documented by DAPI staining and oligonucleosomal DNA laddering. Secondly, AZT treatment inhibited caspase cascade and resulted in (i) diminished caspase-3, -8 and -9 activities and (ii) no fluorescein isothiocynate-[VAD]-fluoromethylketone (FITC-VAD-FMK) in situ labelling in VMV-infected cells treated with AZT. Finally, immunocytochemistry indicated that VMV-infection of SCPC induced the subsequent release of apoptosis inducing factor (AIF), whereas AZT treatment inhibited AIF leakage. Consequently, the anti-apoptotic effects of AZT are not restricted, since AZT treatment blocks all the apoptotic pathways induced during VMV-infection.
Insights
3' azido-2',3'-deoxythymidine (AZT) inhibits visna/maedi virus-induced apoptosis in sheep cells. AZT blocks all viral-induced apoptotic pathways, including caspase activation and AIF release.
Area of Science:
- Neurovirology
- Cellular and Molecular Biology
- Immunology
Background:
- Visna/maedi virus (VMV) causes encephalitis and demyelination in sheep.
- VMV infection induces apoptosis in sheep choroid plexus cells (SCPC) through intrinsic and extrinsic pathways.
- The anti-apoptotic effects of 3' azido-2',3'-deoxythymidine (AZT), an HIV-1 reverse transcriptase inhibitor, on retrovirus-induced apoptosis are unknown.
Purpose of the Study:
- To investigate the broad-range effect of AZT on inhibiting VMV-induced apoptosis in SCPC.
- To determine if AZT can block the different apoptotic pathways activated by VMV infection.
Main Methods:
- Apoptosis detection using DAPI staining and DNA laddering.
- Assessing caspase cascade inhibition via caspase activity assays (caspase-3, -8, -9) and in situ labeling (FITC-VAD-FMK).
- Immunocytochemistry to detect apoptosis-inducing factor (AIF) release.
Main Results:
- AZT treatment inhibited morphological changes and DNA fragmentation associated with apoptosis.
- AZT significantly reduced caspase-3, -8, and -9 activities and blocked FITC-VAD-FMK labeling.
- AZT inhibited the release of apoptosis-inducing factor (AIF) from SCPC during VMV infection.
Conclusions:
- AZT exhibits broad-spectrum anti-apoptotic effects against VMV-induced cell death.
- AZT effectively blocks both intrinsic and extrinsic apoptotic pathways, as well as AIF-mediated apoptosis.
- These findings suggest AZT's potential in managing retroviral infections that trigger apoptosis.
Related Concept Videos
Apoptosis
Inhibition of CDK Activity
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway

